A carregar...
Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer
Although curative resection is the current treatment of choice for localized non-small-cell lung cancer (NSCLC), patients show a wide spectrum of survival even after complete resection of pathological stage I NSCLC. Thus, identifying molecular biomarkers that help to accurately select patients at hi...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4618624/ https://ncbi.nlm.nih.gov/pubmed/26276761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.507 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|